Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00160316
Status:
COMPLETED
Last Update Posted:
2008-03-12
First Post:
2005-09-09
Brief Title:
Endometrial Safety Study of a 05 mg Estradiol and 25 mg Dydrogesterone Combination
Sponsor:
Solvay Pharmaceuticals
Organization:
Solvay Pharmaceuticals
Study Overview
Official Title:
Endometrial Safety of a Low Dose Continuous Combined 17 -EstradiolDydrogesterone Hormone Replacement Regimen E2 05 mg D 25 mg in Postmenopausal Women - A One-Year Open Label Multi-Center Study
Status:
COMPLETED
Status Verified Date:
2008-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to demonstrate endometrial safety of continuous combined 05 mg estradiol and 25 mg dydrogesterone
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004-000227-15 | None | None | None |